SafeHeal: Valuation, Funding & Investors
SafeHeal is a medical device company headquartered in Paris, France, with a U.S. subsidiary, specializing in innovative solutions for colorectal surgery. The company is developing Colovac, a temporary endoluminal bypass device designed to eliminate the need for a temporary stoma in patients undergoing colorectal cancer resection. This device aims to improve patient recovery and quality of life by reducing the complications associated with traditional ostomy procedures. Colovac is currently under investigation in the U.S. and is preparing for a commercial launch in the EU.
Leadership & Board
Latest Estimated Valuation
- Total Amount Raised
- $10M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $10M
- Latest Funding Round
- Series C
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 10, 2025 | Series C | $10.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Sofinnova Partners | Series C |
| M&L Healthcare | Series C |
| Asabys Partners | Series C |
| Solar Eclipse | Series C |
| Gideon Strategic Partners | Series C |
| Polis | Series C |
Similar Companies
A snapshot of private companies similar to SafeHeal, helping you discover and navigate related company profiles.
Related News and Analysis
